Published in Medicine and Law Weekly, October 20th, 2006
Study 1: The potential reductions in perioperative stroke risk with the Symmetry vein graft anastomosis device must be weighed against the potential risk for later adverse events.
According to a study from the United States, "The Symmetry Bypass Connector (St. Jude Medical) was developed to rapidly anastomose saphenous vein grafts to the aorta during coronary bypass surgery (CABG) without cross-clamping. Previous uncontrolled studies of this device observed vein graft closures at 6 months, possibly attributable to neointimal hyperplasia. To assess the long-term...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.